EUVIMEDEUVIMED entdecken
Crossref

The Value of Combined Serum Tumor Markers and Cancer-Associated Autoantibodies for Differentiating Benign and Malignant Pulmonary Nodules

洋 奚

Advances in Clinical Medicine · 2026 · 16 (08) · 1142-1156

DOI: 10.12677/acm.2026.1682889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Clinical Medicine, 2026. Verfasst von 洋 奚. Die Arbeit nennt 19 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

奚, 洋. (2026). The Value of Combined Serum Tumor Markers and Cancer-Associated Autoantibodies for Differentiating Benign and Malignant Pulmonary Nodules. Advances in Clinical Medicine, 16(08), 1142-1156. https://doi.org/10.12677/acm.2026.1682889

Vancouver

奚 洋. The Value of Combined Serum Tumor Markers and Cancer-Associated Autoantibodies for Differentiating Benign and Malignant Pulmonary Nodules. Advances in Clinical Medicine. 2026;16(08):1142-1156. doi:10.12677/acm.2026.1682889

BibTeX
@article{2026,
  author = {奚, 洋},
  title = {The Value of Combined Serum Tumor Markers and Cancer-Associated Autoantibodies for Differentiating Benign and Malignant Pulmonary Nodules},
  journal = {Advances in Clinical Medicine},
  year = {2026},
  volume = {16},
  number = {08},
  pages = {1142--1156},
  doi = {10.12677/acm.2026.1682889}
}
Kostenlos starten →